The global vaginal antifungals market enjoys a valuation of USD 1.09 Billion in 2022, and it is further projected to expand at a CAGR of 4.5% over the forecasted years. According to a recent study by Future Market Insights, Polygenes are leading the market with a share of about 49.0% in the year 2022, within the global market.
Market Outlook
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | USD 1.09 Billion |
| Market Value 2033 | USD 1.76 Billion |
| CAGR 2023 to 2033 | 4.5% |
| Market Share of Top 5 Countries | 61.7% |
| Key Market Players | Pfizer Inc., Bausch Health Companies Inc., ANI Pharmaceuticals, Inc., Hikma Pharmaceuticals Plc, Lupin Limited, Mycovia Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Unique Pharmaceuticals, PEPTONIC Medical AB, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, SCYNEXIS Inc., Basilea Pharmaceutica Ltd., Astellas Pharma Inc., Grupo Ferrer Internacional, S.A.Pacgen Life Science Corporation, NovaDigm Therapeutics, Inc., Cidara Therapeutics, Inc., Amplyx Pharmaceuticals Inc. |
The signs of vaginal fungi infections include bloating near the vagina, burning when urinating, whitish-grey and clumpy vaginal discharge, and many others. Another name for vaginal yeast infection is candidiasis. Bacteria and a small number of yeast cells make up a healthy vagina, but when the ratio of bacteria to yeast changes, the yeast cells have the potential to multiply, which can further cause extreme itching, swelling, and irritation.
Antifungal medications prevent fungal infections from occurring by limiting the growth of fungus microorganisms on the host cell. As a result, the market is being favourably impacted by the availability of a variety of antifungal medications for the treatment of fungal infections as well as availability of over-the-counter medications.
The global sales of the market are anticipated to rise at a CAGR of 4.5% between 2023 and 2033, owing to the rising prevalence of vaginal infectious disease.
The global vaginal antifungals market holds around 7.4% share of the overall global antifungals drug market with a value of around USD 14.74 Billion, in 2022.
Vulvovaginal candidiasis (VVC), which mainly affects immunocompetent childbearing age women, frequently affects the lower female genital tract. Candida albicans is the pathogenic yeast that is most commonly linked to this fungus infection, excluding other non-albicans species.
Significant number of women, according to various scientists, have candida in their vaginas without exhibiting any signs. If the vaginal environment changes to favour Candida development, an infection may result. Hormones, medications, and immune system changes can all trigger infection. Additionally, among women of reproductive age, infectious organisms most frequently cause vulvovaginitis, or inflammation of the vulva and vagina. Candida vulvovaginitis is the root cause of around one-third of these instances.
The VVC emergence can be influenced by a variety of lifestyle factors. Although some studies suggest that excessive use of antibiotics and uncontrolled diabetes in women results in the vaginal fungal infections. Thus, the rising prevalence of diabetic patients in women is propelling the market.
Although, the market is being constrained by the reality that despite how many topical have been developed by the manufacturers, they are ineffective because they do not penetrate the skin well enough. However, the creation of novel products to enhance delivery, absorption, retention, and bioabsorbility in vulvovaginal tissue provides a significant market opportunity for manufacturers and drug developers.
Owing to the above-mentioned factors, the global market is expected to grow at a prominent pace, and reach a valuation of around USD 1.76 Billion during the year 2033.
The market is anticipated to expand due to a rise in the vulvovaginal candidiasis in pregnant women and risk of fungal infection in diabetic patients.
Worldwide, pregnant women are affected by vulvovaginal candidiasis (VVC), a yeast infection of the vulva brought on by species of Candida. Due to a rise in the level of estrogen, which makes it easier for yeast to colonise the vagina pregnant women are more susceptible to developing VVC.
Similarly, antifungals are in high demand due to an increase in the danger of fungal infections in diabetic patients. Diabetes Mellitus has been linked to a number of health problems in women, including yeast infection. Diabetes, or unregulated blood glucose levels, can cause yeast overgrowth in warm and moist regions of the body, especially the vagina.
As a result, the increased risk of fungal infection in diabetes patients, as well as the desire for curative medication, are driving market expansion.
Due to medication side effects and a reduced detection rate as a result of asymptomatic fungal infections, the market is anticipated to slow down.
There is a need for the vaginal infections to be treated because the prevalence of fungi-related diseases is increasing globally. The absence of infection detection, however, is the main hindrance to market expansion. For instance, according to the Centers for Disease Control and Prevention, many fungi illnesses go undetected because of their vague symptoms. In addition, according to the article "Patient education: Bacterial vaginosis (Beyond the Basics)" in UpToDate 2023, around 50 to 75 percent of persons with BV have no symptoms. Hence, the lower detection rate is leading to a limited treatment rate for fungal infections, which is hampering the market.
Similar to this, the market is being gradually restrained by the negative effects of the medication used to treat vaginal fungal infections. For instance, vulvovaginal candidiasis is more common in pregnant women, making them essential for the treatment. Contrarily, animal studies by SCYNEXIS, Inc. suggest that administering the antifungal medication BREXAFEMME to pregnant women could damage the foetus. These serious drug side effects are preventing the industry from expanding. Additionally, diarrhoea, nausea, abdominal pain, and vomiting were the most frequent adverse reactions seen in clinical studies (incidence 2%). As a consequence, the market's development is constrained by the potent side effects of the drugs used to treat a fungus infection.
The USA dominates the global market with a total market share of around 27.0% in 2022, and the same rate of growth is anticipated to continue throughout the forecast period.
Rising prevalence of trichomoniasis in the country is supporting to the market growth for the vaginal antifungals.
Trichomoniasis can make it more probable for people to contract or spread HIV, and it increases the likelihood that women infected with the condition will deliver their babies prematurely and with low birth weights.
Therefore, with the increasing burden of fungal infection diseases, the demand for cure treatments is increasing, which is raising the market.
China has a market share of 12.8% in the global vaginal antifungals market in 2022 due to the upsurge in the high quality health care service in by the government.
As the cornerstone of integrated care, the Chinese government began to investigate the hierarchical diagnostic and treatment system. An institutional innovation in health care reform is the development of medical alliances, which enables hospitals and primary health care (PHC) facilities to collaborate closely to offer disease prevention, treatment, and rehabilitation services across the life course. By the end of 2019, China have created 12,000 medical alliances in order to mobilise high-quality healthcare services from public hospitals to PHC facilities.
Germany holds a market share of 7.6% in 2022 in the global vaginal antifungals market, owing to the government flutter to combat the infectious diseases.
Since 2016, Germany has been a steadfast supporter of Global Antibiotic Research and Development Partnership (GARDP) and has taken the lead in initiatives to combat antibiotic resistance. German government continues to be the largest contributor to GARDP with the new financing, increasing the entirety of its expenditures to EUR 116 million. Over the following five years (2023-2027), the German Federal Ministry of Education and Research pledged a further EUR 50 million in funds for the GARDP. The German financing will enable GARDP to develop novel antibiotic-resistant sickness therapies and ensure that everyone who requires them has access to them.
As a result, increased government funding for antibiotic resistance drugs is propelling the country's vaginal antifungals market.
India has a market share of 8.6% in the global vaginal antifungals market in 2022 due to the rising prevalence of vulvovaginal candidiasis.
Vulvovaginal candidiasis (VVC) is a clinical disease that is frequently seen in India. At least one episode of VVC occurs in at least three-fourths of all women's lifetimes. According to a study published in the Indian Journal of Obstetrics and Gynaecology Research, titled Vulvovaginal Candidiasis: Epidemiology, Treatment, and Prevention Strategies, the prevalence of VVC in India ranges from 10 to 35%.
So, topical treatments for short courses are useful in treating straightforward VVC. In 80%–90% of patients who complete therapy, azole treatment relieves symptoms and produces negative cultures according to CDC 2021. The success of oral and topical therapies for the VVC has led to an increase in the demand for antifungals.
Polygenes are expected to give high growth to the market and holding around 49.0% market share in 2022.
All common fungi that cause systemic infection, including species of Candida, Aspergillus, Mucor, and Cryptococcus, are responsive to amphotericin (belongs to the polyene class of antifungals). For infections caused by the aforementioned species, polyenes are very effective, which is leading to their high adoption. These medications are thought to be the most affordable, secure, and low-toxic antifungal agents available. Therefore, the demand is increasing because polyenes have fewer negative effects.
Topical administration is mostly preferred by the healthcare professional for the treatment purpose. It has a market share of 73.1% in the global market in 2022.
Due to their tailored therapy and limited adverse effects, topical fungal therapies are typically favoured. Due to their unique functional and structural characteristics, advanced topical transporters get beyond biopharmaceutical issues with traditional drug delivery systems, such as poor retention and low bioavailability. Additionally, continuous usage of antifungal medications has the potential to have negative side effects. In order to address this problem, patient cooperation is directed towards topical infection treatment. As a result, the market leader is the topical treatment category.
Bacterial vaginosis holds the market share of 44.9% during the year 2022.
A bacterial imbalance results in overgrowth of bacteria, which leads to bacterial vaginosis (BV), a common vaginal infection. The risk of bacterial vaginosis in pregnant women is increasing, which is also driving market expansion. Preterm birth, early miscarriage, postpartum endometritis, low birth weight, has been observed in women with bacterial vaginosis during pregnancy.
Gynaecology Clinics hold a market share of 41.4% during the year 2022. It is due to the high priority for the gynaecology clinics by the patients. The availability of specialised clinicians and high-tech treatment equipment attracts people to gynaecology clinics. Furthermore, the rising prevalence of vaginal infectious illnesses, combined with increased investment in infrastructure development, is increasing the usage of gynaecology clinics.
Leading companies in the global vaginal antifungals market are seeking for possibilities such as regional expansion to improve their market share. Furthermore, in order to boost their market presence, local rising companies are employing different methods such as mergers, cooperation, acquisition, agreement, and product launches and development in the vaginal antifungals market.
Similarly, recent developments related to companies manufacturing vaginal antifungals products have been tracked by the team at Future Market Insights. These are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and the Middle East & Africa |
| Key Countries Covered | The USA, Canada, Brazil, Mexico, Argentina, The United kingdom, Germany, Italy, Russia, Spain, France, Benelux, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries and South Africa |
| Key Market Segments Covered | Product, Route of Administration, Indication, Distribution Channel, and Region |
| Key Companies Profiled | Pfizer Inc.; Bausch Health Companies Inc; ANI Pharmaceuticals, Inc.; Hikma Pharmaceuticals Plc; Lupin Limited; Mycovia Pharmaceuticals, Inc.; Glenmark Pharmaceuticals Limited; GSK plc.; Aurobindo Pharma Limited; Dr. Reddy's Laboratories; SCYNEXIS, Inc.; Basilea Pharmaceutica Ltd.; Astellas Pharma Inc.; Grupo Ferrer Internacional, S.A.; Pacgen Life Science Corporation; NovaDigm Therapeutics, Inc.; Cidara Therapeutics, Inc.; Amplyx Pharmaceuticals Inc. |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
Table 01: Global Market Size (US$ Million) Analysis and Forecast 2023 to 2033, by Product
Table 02: Global Market Size (US$ Million) Analysis and Forecast 2023 to 2033, by Route of Administration
Table 03: Global Market Size (US$ Million) Analysis and Forecast 2023 to 2033, by Indication
Table 04: Global Market Value (US$ Million) Analysis- and Forecast 2023 to 2033, by Distribution Channel
Table 05: Global Market Value (US$ Million) Analysis- and Forecast 2023 to 2033, by Region
Table 06: North America Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Country
Table 07: North America Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Product
Table 08: North America Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Route of Administration
Table 09: North America Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Indication
Table 10: North America Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Distribution Channel
Table 11: Latin America Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Country
Table 12: Latin America Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Product
Table 13: Latin America Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Route of Administration
Table 14: Latin America Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Indication
Table 15: Latin America Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Distribution Channel
Table 16: Europe Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Country
Table 17: Europe Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Product
Table 18: Europe Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Route of Administration
Table 19: Europe Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Indication
Table 20: Europe Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Distribution Channel
Table 21: South Asia Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Country
Table 22: South Asia Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Product
Table 23: South Asia Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Route of Administration
Table 24: South Asia Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Indication
Table 25: South Asia Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Distribution Channel
Table 26: East Asia Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Country
Table 27: East Asia Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Product
Table 28: East Asia Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Route of Administration
Table 29: East Asia Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Indication
Table 30: East Asia Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Distribution Channel
Table 31: Oceania Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Country
Table 32: Oceania Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Product
Table 33: Oceania Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Route of Administration
Table 34: Oceania Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Indication
Table 35: Oceania Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Distribution Channel
Table 36: Middle East & Africa Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Country
Table 37: Middle East & Africa Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Product
Table 38: Middle East & Africa Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Route of Administration
Table 39: Middle East & Africa Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Indication
Table 40: Middle East & Africa Market Size Analysis 2018 to 2022 and Forecast 2023 to 2033, by Distribution Channel
Figure 01: Global Market Value Analysis (US$ Million), 2018 to 2022
Figure 02: Global Market Value Forecast (US$ Million), 2022 to 2033
Figure 03: Global Market Absolute $ Opportunity, 2022 to 2033
Figure 04: Global Market Share Analysis (%), by Product, 2023 & 2033
Figure 05: Global Market Y-o-Y Analysis (%), by Product, 2023 to 2033
Figure 06: Global Market Attractiveness Analysis by Product, 2023 to 2033
Figure 07: Global Market Share Analysis (%), by Route of Administration, 2023 & 2033
Figure 08: Global Market Y-o-Y Analysis (%), by Route of Administration, 2023 to 2033
Figure 09: Global Market Attractiveness Analysis by Route of Administration, 2023 to 2033
Figure 10: Global Market Share Analysis (%), by Indication, 2023 & 2033
Figure 11: Global Market Y-o-Y Analysis (%), by Indication, 2023 to 2033
Figure 12: Global Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 13: Global Market Share Analysis (%), by Distribution Channel, 2023 & 2033
Figure 14: Global Market Y-o-Y Analysis (%), by Distribution Channel, 2023 to 2033
Figure 15: Global Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 16: Global Market Share Analysis (%), by Region, 2023 & 2033
Figure 17: Global Market Y-o-Y Analysis (%), by Region, 2023 to 2033
Figure 18: Global Market Attractiveness Analysis by Region, 2023 to 2033
Figure 19: North America Market Value Share by Product 2023 (E)
Figure 20: North America Market Value Share by Route of Administration 2023 (E)
Figure 21: North America Market Value Share by Indication 2023 (E)
Figure 22: North America Market Value Share by Distribution Channel 2023 (E)
Figure 23: North America Market Value Share by Country 2023 (E)
Figure 24: North America Market Historical Market Size (US$ Million) Analysis, 2018 to 2022
Figure 25: North America Market Current and Future Market Size (US$ Million), 2022 to 2033 & Y-o-Y Growth Trend Analysis
Figure 26: North America Market Attractiveness Analysis by Product, 2023 to 2033
Figure 27: North America Market Attractiveness Analysis by Route of Administration, 2023 to 2033
Figure 28: North America Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 29: North America Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 30: North America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 31: USA Market Value Proportion Analysis, 2022
Figure 32: USA Market Share Analysis (%), by Product, 2022 & 2033
Figure 33: USA Market Share Analysis (%), by Route of Administration, 2022 & 2033
Figure 34: USA Market Share Analysis (%), by Indication, 2022 & 2033
Figure 35: USA Market Share Analysis (%), by Distribution Channel, 2022 & 2033
Figure 36: Canada Market Value Proportion Analysis, 2022
Figure 37: Canada Market Share Analysis (%), by Product, 2022 & 2033
Figure 38: Canada Market Share Analysis (%), by Route of Administration, 2022 & 2033
Figure 39: Canada Market Share Analysis (%), by Indication, 2022 & 2033
Figure 40: Canada Market Share Analysis (%), by Distribution Channel, 2022 & 2033
Figure 41: Latin America Market Value Share by Product 2023 (E)
Figure 42: Latin America Market Value Share by Route of Administration 2023 (E)
Figure 43: Latin America Market Value Share by Indication 2023 (E)
Figure 44: Latin America Market Value Share by Distribution Channel 2023 (E)
Figure 45: Latin America Market Value Share by Country 2023 (E)
Figure 46: Latin America Market Historical Market Size (US$ Million) Analysis, 2018 to 2022
Figure 47: Latin America Market Current and Future Market Size (US$ Million), 2022 to 2033 & Y-o-Y Growth Trend Analysis
Figure 48: Latin America Market Attractiveness Analysis by Product, 2023 to 2033
Figure 49: Latin America Market Attractiveness Analysis by Route of Administration, 2023 to 2033
Figure 50: Latin America Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 51: Latin America Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 52: Latin America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 53: Brazil Market Value Proportion Analysis, 2022
Figure 54: Brazil Market Share Analysis (%), by Product, 2022 & 2033
Figure 55: Brazil Market Share Analysis (%), by Route of Administration, 2022 & 2033
Figure 56: Brazil Market Share Analysis (%), by Indication, 2022 & 2033
Figure 57: Brazil Market Share Analysis (%), by Distribution Channel, 2022 & 2033
Figure 58: Mexico Market Value Proportion Analysis, 2022
Figure 59: Mexico Market Share Analysis (%), by Product, 2022 & 2033
Figure 60: Mexico Market Share Analysis (%), by Route of Administration, 2022 & 2033
Figure 61: Mexico Market Share Analysis (%), by Indication, 2022 & 2033
Figure 62: Mexico Market Share Analysis (%), by Distribution Channel, 2022 & 2033
Figure 63: Argentina Market Value Proportion Analysis, 2022
Figure 64: Argentina Market Share Analysis (%), by Product, 2022 & 2033
Figure 65: Argentina Market Share Analysis (%), by Route of Administration, 2022 & 2033
Figure 66: Argentina Market Share Analysis (%), by Indication, 2022 & 2033
Figure 67: Argentina Market Share Analysis (%), by Distribution Channel, 2022 & 2033
Figure 68: Europe Market Value Share by Product 2023 (E)
Figure 69: Europe Market Value Share by Route of Administration 2023 (E)
Figure 70: Europe Market Value Share by Indication 2023 (E)
Figure 71: Europe Market Value Share by Distribution Channel 2023 (E)
Figure 72: Europe Market Value Share by Country 2023 (E)
Figure 73: Europe Market Historical Market Size (US$ Million) Analysis, 2018 to 2022
Figure 74: Europe Market Current and Future Market Size (US$ Million), 2022 to 2033 & Y-o-Y Growth Trend Analysis
Figure 75: Europe Market Attractiveness Analysis by Product, 2023 to 2033
Figure 76: Europe Market Attractiveness Analysis by Route of Administration, 2023 to 2033
Figure 77: Europe Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 78: Europe Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 79: Europe Market Attractiveness Analysis by Country, 2023 to 2033
Figure 80: Italy Market Value Proportion Analysis, 2022
Figure 81: Italy Market Share Analysis (%), by Product, 2022 & 2033
Figure 82: Italy Market Share Analysis (%), by Route of Administration, 2022 & 2033
Figure 83: Italy Market Share Analysis (%), by Indication, 2022 & 2033
Figure 84: Italy Market Share Analysis (%), by Distribution Channel, 2022 & 2033
Figure 85: Germany Market Value Proportion Analysis, 2022
Figure 86: Germany Market Share Analysis (%), by Product, 2022 & 2033
Figure 87: Germany Market Share Analysis (%), by Route of Administration, 2022 & 2033
Figure 88: Germany Market Share Analysis (%), by Indication, 2022 & 2033
Figure 89: Germany Market Share Analysis (%), by Distribution Channel, 2022 & 2033
Figure 90: United kingdom Market Value Proportion Analysis, 2022
Figure 91: United kingdom Market Share Analysis (%), by Product, 2022 & 2033
Figure 92: United kingdom Market Share Analysis (%), by Route of Administration, 2022 & 2033
Figure 93: United kingdom Market Share Analysis (%), by Indication, 2022 & 2033
Figure 94: United kingdom Market Share Analysis (%), by Distribution Channel, 2022 & 2033
Figure 95: France Market Value Proportion Analysis, 2022
Figure 96: France Market Share Analysis (%), by Product, 2022 & 2033
Figure 97: France Market Share Analysis (%), by Route of Administration, 2022 & 2033
Figure 98: France Market Share Analysis (%), by Indication, 2022 & 2033
Figure 99: France Market Share Analysis (%), by Distribution Channel, 2022 & 2033
Figure 100: Spain Market Value Proportion Analysis, 2022
Figure 101: Spain Market Share Analysis (%), by Product, 2022 & 2033
Figure 102: Spain Market Share Analysis (%), by Route of Administration, 2022 & 2033
Figure 103: Spain Market Share Analysis (%), by Indication, 2022 & 2033
Figure 104: Spain Market Share Analysis (%), by Distribution Channel, 2022 & 2033
Figure 105: BENELUX Market Value Proportion Analysis, 2022
Figure 106: BENELUX Market Share Analysis (%), by Product, 2022 & 2033
Figure 107: BENELUX Market Share Analysis (%), by Route of Administration, 2022 & 2033
Figure 108: BENELUX Market Share Analysis (%), by Indication, 2022 & 2033
Figure 109: BENELUX Market Share Analysis (%), by Distribution Channel, 2022 & 2033
Figure 110: Nordic Countries Market Value Proportion Analysis, 2022
Figure 111: Nordic Countries Market Share Analysis (%), by Product, 2022 & 2033
Figure 112: Nordic Countries Market Share Analysis (%), by Route of Administration, 2022 & 2033
Figure 113: Nordic Countries Market Share Analysis (%), by Indication, 2022 & 2033
Figure 114: Nordic Countries Market Share Analysis (%), by Distribution Channel, 2022 & 2033
Figure 115: Russia Market Value Proportion Analysis, 2022
Figure 116: Russia Market Share Analysis (%), by Product, 2022 & 2033
Figure 117: Russia Market Share Analysis (%), by Route of Administration, 2022 & 2033
Figure 118: Russia Market Share Analysis (%), by Indication, 2022 & 2033
Figure 119: Russia Market Share Analysis (%), by Distribution Channel, 2022 & 2033
Figure 120: South Asia Market Value Share by Product 2023 (E)
Figure 121: South Asia Market Value Share by Route of Administration 2023 (E)
Figure 122: South Asia Market Value Share by Indication 2023 (E)
Figure 123: South Asia Market Value Share by Distribution Channel 2023 (E)
Figure 124: South Asia Market Value Share by Country 2023 (E)
Figure 125: South Asia Market Historical Market Size (US$ Million) Analysis, 2018 to 2022
Figure 126: South Asia Market Current and Future Market Size (US$ Million), 2022 to 2033 & Y-o-Y Growth Trend Analysis
Figure 127: South Asia Market Attractiveness Analysis by Product, 2023 to 2033
Figure 128: South Asia Market Attractiveness Analysis by Route of Administration, 2023 to 2033
Figure 129: South Asia Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 130: South Asia Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 131: South Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 132: India Market Value Proportion Analysis, 2022
Figure 133: India Market Share Analysis (%), by Product, 2022 & 2033
Figure 134: India Market Share Analysis (%), by Route of Administration, 2022 & 2033
Figure 135: India Market Share Analysis (%), by Indication, 2022 & 2033
Figure 136: India Market Share Analysis (%), by Distribution Channel, 2022 & 2033
Figure 137: Thailand Market Value Proportion Analysis, 2022
Figure 138: Thailand Market Share Analysis (%), by Product, 2022 & 2033
Figure 139: Thailand Market Share Analysis (%), by Route of Administration, 2022 & 2033
Figure 140: Thailand Market Share Analysis (%), by Indication, 2022 & 2033
Figure 141: Thailand Market Share Analysis (%), by Distribution Channel, 2022 & 2033
Figure 142: Indonesia Market Value Proportion Analysis, 2022
Figure 143: Indonesia Market Share Analysis (%), by Product, 2022 & 2033
Figure 144: Indonesia Market Share Analysis (%), by Route of Administration, 2022 & 2033
Figure 145: Indonesia Market Share Analysis (%), by Indication, 2022 & 2033
Figure 146: Indonesia Market Share Analysis (%), by Distribution Channel, 2022 & 2033
Figure 147: Malaysia Market Value Proportion Analysis, 2022
Figure 148: Malaysia Market Share Analysis (%), by Product, 2022 & 2033
Figure 149: Malaysia Market Share Analysis (%), by Route of Administration, 2022 & 2033
Figure 150: Malaysia Market Share Analysis (%), by Indication, 2022 & 2033
Figure 151: Malaysia Market Share Analysis (%), by Distribution Channel, 2022 & 2033
Figure 152: East Asia Market Value Share by Product 2023 (E)
Figure 153: East Asia Market Value Share by Route of Administration 2023 (E)
Figure 154: East Asia Market Value Share by Indication 2023 (E)
Figure 155: East Asia Market Value Share by Distribution Channel 2023 (E)
Figure 156: East Asia Market Value Share by Country 2023 (E)
Figure 157: East Asia Market Historical Market Size (US$ Million) Analysis, 2018 to 2022
Figure 158: East Asia Market Current and Future Market Size (US$ Million), 2022 to 2033 & Y-o-Y Growth Trend Analysis
Figure 159: East Asia Market Attractiveness Analysis by Product, 2023 to 2033
Figure 160: East Asia Market Attractiveness Analysis by Route of Administration, 2023 to 2033
Figure 161: East Asia Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 162: East Asia Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 163: East Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 164: China Market Value Proportion Analysis, 2022
Figure 165: China Market Share Analysis (%), by Product, 2022 & 2033
Figure 166: China Market Share Analysis (%), by Route of Administration, 2022 & 2033
Figure 167: China Market Share Analysis (%), by Indication, 2022 & 2033
Figure 168: China Market Share Analysis (%), by Distribution Channel, 2022 & 2033
Figure 169: Japan Market Value Proportion Analysis, 2022
Figure 170: Japan Market Share Analysis (%), by Product, 2022 & 2033
Figure 171: Japan Market Share Analysis (%), by Route of Administration, 2022 & 2033
Figure 172: Japan Market Share Analysis (%), by Indication, 2022 & 2033
Figure 173: Japan Market Share Analysis (%), by Distribution Channel, 2022 & 2033
Figure 174: South Korea Market Value Proportion Analysis, 2022
Figure 175: South Korea Market Share Analysis (%), by Product, 2022 & 2033
Figure 176: South Korea Market Share Analysis (%), by Route of Administration, 2022 & 2033
Figure 177: South Korea Market Share Analysis (%), by Indication, 2022 & 2033
Figure 178: South Korea Market Share Analysis (%), by Distribution Channel, 2022 & 2033
Figure 179: Oceania Market Value Share by Product 2023 (E)
Figure 180: Oceania Market Value Share by Route of Administration 2023 (E)
Figure 181: Oceania Market Value Share by Indication 2023 (E)
Figure 182: Oceania Market Value Share by Distribution Channel 2023 (E)
Figure 183: Oceania Market Value Share by Country 2023 (E)
Figure 184: Oceania Market Historical Market Size (US$ Million) Analysis, 2018 to 2022
Figure 185: Oceania Market Current and Future Market Size (US$ Million), 2022 to 2033 & Y-o-Y Growth Trend Analysis
Figure 186: Oceania Market Attractiveness Analysis by Product, 2023 to 2033
Figure 187: Oceania Market Attractiveness Analysis by Route of Administration, 2023 to 2033
Figure 188: Oceania Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 189: Oceania Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 190: Oceania Market Attractiveness Analysis by Country, 2023 to 2033
Figure 191: Australia Market Value Proportion Analysis, 2022
Figure 192: Australia Market Share Analysis (%), by Product, 2022 & 2033
Figure 193: Australia Market Share Analysis (%), by Route of Administration, 2022 & 2033
Figure 194: Australia Market Share Analysis (%), by Indication, 2022 & 2033
Figure 195: Australia Market Share Analysis (%), by Distribution Channel, 2022 & 2033
Figure 196: New Zealand Market Value Proportion Analysis, 2022
Figure 197: New Zealand Market Share Analysis (%), by Product, 2022 & 2033
Figure 198: New Zealand Market Share Analysis (%), by Route of Administration, 2022 & 2033
Figure 199: New Zealand Market Share Analysis (%), by Indication, 2022 & 2033
Figure 200: New Zealand Market Share Analysis (%), by Distribution Channel, 2022 & 2033
Figure 201: Middle East & Africa Market Value Share by Product 2023 (E)
Figure 202: Middle East & Africa Market Value Share by Route of Administration 2023 (E)
Figure 203: Middle East & Africa Market Value Share by Indication 2023 (E)
Figure 204: Middle East & Africa Market Value Share by Distribution Channel 2023 (E)
Figure 205: Middle East & Africa Market Value Share by Country 2023 (E)
Figure 206: Middle East & Africa Market Historical Market Size (US$ Million) Analysis, 2018 to 2022
Figure 207: Middle East & Africa Market Current and Future Market Size (US$ Million), 2022 to 2033 & Y-o-Y Growth Trend Analysis
Figure 208: Middle East & Africa Market Attractiveness Analysis by Product, 2023 to 2033
Figure 209: Middle East & Africa Market Attractiveness Analysis by Route of Administration, 2023 to 2033
Figure 210: Middle East & Africa Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 211: Middle East & Africa Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 212: Middle East & Africa Market Attractiveness Analysis by Country, 2023 to 2033
Figure 213: GCC Countries Market Value Proportion Analysis, 2022
Figure 214: GCC Countries Market Share Analysis (%), by Product, 2022 & 2033
Figure 215: GCC Countries Market Share Analysis (%), by Route of Administration, 2022 & 2033
Figure 216: GCC Countries Market Share Analysis (%), by Indication, 2022 & 2033
Figure 217: GCC Countries Market Share Analysis (%), by Distribution Channel, 2022 & 2033
Figure 218: Türkiye Market Value Proportion Analysis, 2022
Figure 219: Türkiye Market Share Analysis (%), by Product, 2022 & 2033
Figure 220: Türkiye Market Share Analysis (%), by Route of Administration, 2022 & 2033
Figure 221: Türkiye Market Share Analysis (%), by Indication, 2022 & 2033
Figure 222: Türkiye Market Share Analysis (%), by Distribution Channel, 2022 & 2033
Figure 223: South Africa Market Value Proportion Analysis, 2022
Figure 224: South Africa Market Share Analysis (%), by Product, 2022 & 2033
Figure 225: South Africa Market Share Analysis (%), by Route of Administration, 2022 & 2033
Figure 226: South Africa Market Share Analysis (%), by Indication, 2022 & 2033
Figure 227: South Africa Market Share Analysis (%), by Distribution Channel, 2022 & 2033
Figure 228: North Africa Market Value Proportion Analysis, 2022
Figure 229: North Africa Market Share Analysis (%), by Product, 2022 & 2033
Figure 230: North Africa Market Share Analysis (%), by Route of Administration, 2022 & 2033
Figure 231: North Africa Market Share Analysis (%), by Indication, 2022 & 2033
Figure 232: North Africa Market Share Analysis (%), by Distribution Channel, 2022 & 2033
The CAGR of the market is 4.5% through 2033.
The global market size to reach USD 1.76 Billion by 2033.
With a market share of 27.0%, the United States governs the global market.
China possesses a 12.8% market share in the market.
The market has slowed notably owing to side effects from drugs and a lower identification rate as a consequence of asymptomatic fungal infections.
Due to a spike in vulvovaginal candidiasis in pregnant ladies and the potential of fungal infection in diabetics, the market is set to expand.
Vaginal Antifungals Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
